MyIDEA
DeviceAn educational tablet app that is customized to the patient based on the data in the Electronic Health Record.
NCT Number: NCT04439864
This is a randomized clinical trial evaluating the educational program called My Interventional Drug Eluting Stent Educational App (MyIDEA) that is a pilot at two sites.
Looking for future studies?
Notify Me50 year and older
All sexes
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
An educational tablet app that is customized to the patient based on the data in the Electronic Health Record.
Time frame: 3 months
Would research participants enroll and follow up in a study of tablet based education. Do patients think they know everything? Would patients enrolled in the control arm still follow up in the study?
Time frame: 3 months
A measure of Pharmacy days covered for DAPT medication. The patients after recieving a Drug Eluting Stent need to adhere to Dual Antiplatlet Therapy (DAPT) to prevent restenosis of the stent. PDC is a calculation of the DAPT which is Aspirin and an ADP receptor antagonist. As aspirin is over the counter, the pharmacy does not have a record of purchase so the PDC was calculated for the ADP receptor antagonis.
University of Illinois at Chicago
Other
Perspectives Post Percutaneous Coronary Intervention Randomized Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07728604
Behavior, Health Behavior
Izmir, Turkey (Türkiye)
View Trial DetailsNCT06569290
Behavior, Diabetes
Boston, Massachusetts, United States
View Trial DetailsNCT05349422
Behavior, Blood Pressure
New York, United States
View Trial DetailsNCT06000813
Behavior, Diabetes Mellitus
Boston, Massachusetts, United States
View Trial Details